Interferon Alpha-2a Biosimilar Market Report

Global and Region Interferon Alpha-2a Biosimilar Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 31, 2022
  • PAGES：194
  • REPORT CODE：GMM927169
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Interferon a (human leukocyte protein moiety reduced). A type I interferon consisting of 165 amino acid residues with lysine in position 23. This protein is produced by recombinant DNA technology and resembles interferon secreted by leukocytes. It is used extensively as an antiviral or antineoplastic agent. An oral form is being developed by Amarillo Biosciences.

    The global average price of Interferon Alpha-2a Biosimilar is in the decreasing trend, from 186.78 USD/Unit in 2013 to 64.67 USD/Unit in 2017. With the situation of global economy, prices will be in decreasing trend in the following five years.The classification of Interferon Alpha-2a Biosimilar includes ordinary type and long-lasting type, and the proportion of ordinary type in 2017 is about 64%, and the proportion is in increasing trend from 2013 to 2017.Interferon Alpha-2a Biosimilar is widely used for hepatitis C, hepatitis B and other diseases. The most proportion of Interferon Alpha-2a Biosimilar is used for hepatitis C, and the proportion in 2017 is 46%. Europe is the largest supplier of Interferon Alpha-2a Biosimilar, with a production market share nearly 70% in 2017. South America is the largest consumption place, with a consumption market share nearly 26% in 2017. Following South America, Europe is the second largest consumption place with the consumption market share of 22%. Market competition is not intense. Amega Biotech, 3sbio, Roche, PROBIOMED, Biosidus, Rhein Minapharm Biogenetics, Zydus Cadila, Nanogen, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.

    The report details the trend, potential and market size of Interferon Alpha-2a Biosimilar market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Interferon Alpha-2a Biosimilarmarket, defines the market attractiveness level of Interferon Alpha-2a Biosimilar market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Interferon Alpha-2a Biosimilar industry, describes the types of Interferon Alpha-2a Biosimilar market, the applications of major players and the market size, and deeply analyzes the current situation of the global Interferon Alpha-2a Biosimilar market and the development prospects and opportunities of Interferon Alpha-2a Biosimilar industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Interferon Alpha-2a Biosimilar market in Chapter 13.

    By Player:

    • Amega Biotech

    • 3sbio

    • Roche

    • PROBIOMED

    • Biosidus

    • Rhein Minapharm Biogenetics

    • Zydus Cadila

    • Nanogen

    By Type:

    • Long-lasting Type

    • Ordinary Type

    By End-User:

    • Hepatitis C

    • Hepatitis B

    • Other

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Interferon Alpha-2a Biosimilar Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Interferon Alpha-2a Biosimilar Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Interferon Alpha-2a Biosimilar Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Interferon Alpha-2a Biosimilar Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Interferon Alpha-2a Biosimilar Market Analysis and Outlook to 2022

    • 7.1 Global Interferon Alpha-2a Biosimilar Consumption (2017-2022)

    • 7.2 United States Interferon Alpha-2a Biosimilar Consumption (2017-2022)

    • 7.3 Europe Interferon Alpha-2a Biosimilar Consumption (2017-2022)

    • 7.4 China Interferon Alpha-2a Biosimilar Consumption (2017-2022)

    • 7.5 Japan Interferon Alpha-2a Biosimilar Consumption (2017-2022)

    • 7.6 India Interferon Alpha-2a Biosimilar Consumption (2017-2022)

    • 7.7 South Korea Interferon Alpha-2a Biosimilar Consumption (2017-2022)

    8 Region and Country-wise Interferon Alpha-2a Biosimilar Market Analysis and Outlook to 2028

    • 8.1 Global Interferon Alpha-2a Biosimilar Consumption Forecast (2022-2028)

    • 8.2 United States Interferon Alpha-2a Biosimilar Consumption Forecast (2022-2028)

    • 8.3 Europe Interferon Alpha-2a Biosimilar Consumption Forecast (2022-2028)

    • 8.4 China Interferon Alpha-2a Biosimilar Consumption Forecast (2022-2028)

    • 8.5 Japan Interferon Alpha-2a Biosimilar Consumption Forecast (2022-2028)

    • 8.6 India Interferon Alpha-2a Biosimilar Consumption Forecast (2022-2028)

    • 8.7 South Korea Interferon Alpha-2a Biosimilar Consumption Forecast (2022-2028)

    9 Global Interferon Alpha-2a Biosimilar Market Outlook by Types and Applications to 2022

    • 9.1 Global Interferon Alpha-2a Biosimilar Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Long-lasting Type Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Ordinary Type Consumption and Growth Rate (2017-2022)

    • 9.2 Global Interferon Alpha-2a Biosimilar Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hepatitis C Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Hepatitis B Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Other Consumption and Growth Rate (2017-2022)

    10 Global Interferon Alpha-2a Biosimilar Market Outlook by Types and Applications to 2028

    • 10.1 Global Interferon Alpha-2a Biosimilar Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Long-lasting Type Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Ordinary Type Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Interferon Alpha-2a Biosimilar Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hepatitis C Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Hepatitis B Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)

    11 Global Interferon Alpha-2a Biosimilar Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Interferon Alpha-2a Biosimilar Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Interferon Alpha-2a Biosimilar Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Interferon Alpha-2a Biosimilar Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Interferon Alpha-2a Biosimilar Market Competitive Analysis

    • 14.1 Amega Biotech

      • 14.1.1 Amega Biotech Company Details

      • 14.1.2 Amega Biotech Interferon Alpha-2a Biosimilar Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Amega Biotech Interferon Alpha-2a Biosimilar Product and Service

    • 14.2 3sbio

      • 14.2.1 3sbio Company Details

      • 14.2.2 3sbio Interferon Alpha-2a Biosimilar Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 3sbio Interferon Alpha-2a Biosimilar Product and Service

    • 14.3 Roche

      • 14.3.1 Roche Company Details

      • 14.3.2 Roche Interferon Alpha-2a Biosimilar Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Roche Interferon Alpha-2a Biosimilar Product and Service

    • 14.4 PROBIOMED

      • 14.4.1 PROBIOMED Company Details

      • 14.4.2 PROBIOMED Interferon Alpha-2a Biosimilar Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 PROBIOMED Interferon Alpha-2a Biosimilar Product and Service

    • 14.5 Biosidus

      • 14.5.1 Biosidus Company Details

      • 14.5.2 Biosidus Interferon Alpha-2a Biosimilar Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Biosidus Interferon Alpha-2a Biosimilar Product and Service

    • 14.6 Rhein Minapharm Biogenetics

      • 14.6.1 Rhein Minapharm Biogenetics Company Details

      • 14.6.2 Rhein Minapharm Biogenetics Interferon Alpha-2a Biosimilar Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Rhein Minapharm Biogenetics Interferon Alpha-2a Biosimilar Product and Service

    • 14.7 Zydus Cadila

      • 14.7.1 Zydus Cadila Company Details

      • 14.7.2 Zydus Cadila Interferon Alpha-2a Biosimilar Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Zydus Cadila Interferon Alpha-2a Biosimilar Product and Service

    • 14.8 Nanogen

      • 14.8.1 Nanogen Company Details

      • 14.8.2 Nanogen Interferon Alpha-2a Biosimilar Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Nanogen Interferon Alpha-2a Biosimilar Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Interferon Alpha-2a Biosimilar

    • Figure Interferon Alpha-2a Biosimilar Picture

    • Table Global Interferon Alpha-2a Biosimilar Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Interferon Alpha-2a Biosimilar Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Interferon Alpha-2a Biosimilar Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Interferon Alpha-2a Biosimilar Consumption by Country (2017-2022)

    • Figure United States Interferon Alpha-2a Biosimilar Consumption and Growth Rate (2017-2022)

    • Table Europe Interferon Alpha-2a Biosimilar Consumption and Growth Rate (2017-2022)

    • Figure China Interferon Alpha-2a Biosimilar Consumption and Growth Rate (2017-2022)

    • Figure Japan Interferon Alpha-2a Biosimilar Consumption and Growth Rate (2017-2022)

    • Figure India Interferon Alpha-2a Biosimilar Consumption and Growth Rate (2017-2022)

    • Figure South Korea Interferon Alpha-2a Biosimilar Consumption and Growth Rate (2017-2022)

    • Figure Global Interferon Alpha-2a Biosimilar Consumption Forecast by Country (2022-2028)

    • Figure United States Interferon Alpha-2a Biosimilar Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Interferon Alpha-2a Biosimilar Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Interferon Alpha-2a Biosimilar Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Interferon Alpha-2a Biosimilar Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Interferon Alpha-2a Biosimilar Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Interferon Alpha-2a Biosimilar Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Long-lasting Type Consumption and Growth Rate (2017-2022)

    • Figure Global Ordinary Type Consumption and Growth Rate (2017-2022)

    • Figure Global Hepatitis C Consumption and Growth Rate (2017-2022)

    • Figure Global Hepatitis B Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Long-lasting Type Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ordinary Type Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hepatitis C Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hepatitis B Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Interferon Alpha-2a Biosimilar Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Interferon Alpha-2a Biosimilar Export by Region (Top 5 Countries) (2017-2028)

    • Table Amega Biotech (Foundation Year, Company Profile and etc.)

    • Table Amega Biotech Interferon Alpha-2a Biosimilar Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amega Biotech Interferon Alpha-2a Biosimilar Product and Service

    • Table 3sbio (Foundation Year, Company Profile and etc.)

    • Table 3sbio Interferon Alpha-2a Biosimilar Sales, Price, Value and Gross Profit (2017-2022)

    • Table 3sbio Interferon Alpha-2a Biosimilar Product and Service

    • Table Roche (Foundation Year, Company Profile and etc.)

    • Table Roche Interferon Alpha-2a Biosimilar Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roche Interferon Alpha-2a Biosimilar Product and Service

    • Table PROBIOMED (Foundation Year, Company Profile and etc.)

    • Table PROBIOMED Interferon Alpha-2a Biosimilar Sales, Price, Value and Gross Profit (2017-2022)

    • Table PROBIOMED Interferon Alpha-2a Biosimilar Product and Service

    • Table Biosidus (Foundation Year, Company Profile and etc.)

    • Table Biosidus Interferon Alpha-2a Biosimilar Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biosidus Interferon Alpha-2a Biosimilar Product and Service

    • Table Rhein Minapharm Biogenetics (Foundation Year, Company Profile and etc.)

    • Table Rhein Minapharm Biogenetics Interferon Alpha-2a Biosimilar Sales, Price, Value and Gross Profit (2017-2022)

    • Table Rhein Minapharm Biogenetics Interferon Alpha-2a Biosimilar Product and Service

    • Table Zydus Cadila (Foundation Year, Company Profile and etc.)

    • Table Zydus Cadila Interferon Alpha-2a Biosimilar Sales, Price, Value and Gross Profit (2017-2022)

    • Table Zydus Cadila Interferon Alpha-2a Biosimilar Product and Service

    • Table Nanogen (Foundation Year, Company Profile and etc.)

    • Table Nanogen Interferon Alpha-2a Biosimilar Sales, Price, Value and Gross Profit (2017-2022)

    • Table Nanogen Interferon Alpha-2a Biosimilar Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US